Markets.com Logo

DVAX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --$
  • Previous Close
    --$
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

DVAX.US represents Dynavax Technologies Corporation, a commercial-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Their primary product is HEPLISAV-B, a hepatitis B vaccine approved for adults in the United States and Europe. Dynavax also has a portfolio of CpG 1018 adjuvant products, which can enhance the immune response of vaccines. The company's financial performance is heavily influenced by HEPLISAV-B sales, licensing agreements, and research and development activities related to their adjuvant technology.

Factors

DVAX.US stock price is influenced by various factors. Product Pipeline Progress: Positive clinical trial results and regulatory approvals for Dynavax's vaccines, particularly Heplisav-B, typically boost the stock price.

Competition: Developments in the hepatitis B vaccine market and emergence of competing products can negatively impact Dynavax's market share and stock price.

Market Sentiment: Overall market conditions and investor sentiment towards biotechnology stocks can affect DVAX.US, irrespective of company-specific news.

Financial Performance: Dynavax's revenue, earnings, and profitability directly influence investor confidence and stock valuation.

Partnerships and Collaborations: Strategic alliances with other companies for vaccine development or commercialization can positively impact the stock.

Regulatory Environment: Changes in regulations related to vaccines or healthcare policies can affect Dynavax's business operations and stock price.

Manufacturing and Supply Chain: Disruptions in manufacturing or supply chain issues can negatively affect vaccine production and impact the stock.

Economic Conditions: Economic downturns can affect healthcare spending and potentially impact demand for vaccines, influencing DVAX.US.

Company News and Announcements: Major announcements regarding product development, partnerships, or financial results can trigger significant stock price movements.

People Also Watch

Latest news

GOOGL Share Price Analysis: Why Alphabet Stock Is Up Today?

Frances Wang|--

Stock market today: Hang Seng Dips, Nikkei Gains. Dow jumps

Frances Wang|--

Morning Note: RBNZ Eases Policy; Aussie Inflation Surprises; Tesla Struggles in Europe

Tommy Yap|--

Latest Education Articles

Crypto stocks to watch: Coinbase, Robinhood, Strategy, Tesla

Frances Wang|--

NVDA stock analysis: What are the expectations for Nvidia Q1 earnings?

Frances Wang|--

AMD stock analysis: Where is AMD stock expected to go?

Frances Wang|--